Established in 2002, DuChemBio Co., Ltd. is a leading South Korean company specializing in the development, production, and sale of radiopharmaceuticals for cancer diagnosis and treatment. The company focuses on providing advanced diagnostic solutions for neurological disorders and various types of cancers.

FP-CIT: Used for diagnosing Parkinson's disease and Parkinson's syndrome by measuring the density of dopamine transporters in the brain striatum.​ F-DOPA: Utilized for brain tumor diagnosis with neutralization technology.​ Neuraceq: Assists in diagnosing Alzheimer's disease by measuring the distribution and density of beta-amyloid in the brain.​ Vizamyl: Facilitates early diagnosis of beta-amyloid in Alzheimer's disease.​

Public

Pharma